Moberg Pharma publishes information document on the proposed divestment of the OTC-business
STOCKHOLM, February 4th, 2019. On February 12th, 2019, it was announced that Moberg Pharma AB (publ) (“Moberg Pharma” or the “Company”) has entered into agreement with RoundTable Healthcare Partners and Signet Healthcare Partners to divest its entire commercial operations. Further information regarding the proposed divestment of the OTC-business has today been published and is available in the form of an information document.The information document describes the proposed transaction as well as the Company’s continued operations following a divestment of the OTC-business. The information